
Axcella Health AXLA
$ 4.58
-16.42%
Quarterly report 2023-Q2
added 08-03-2023
Country |
![]() |
IPO year |
2019 |
Industry |
Biotechnology |
Stock Exchange |
NASDAQ GLOBAL |
CEO |
Mr. William Hinshaw |
Employees in the company |
66 |
Shares |
54.4 M |
Market Cap[1] |
$ 249 M |
EBITDA (LTM) |
$ -59.7 M |
P/E (LTM) |
-0.23 |
P/S (LTM) |
21.09 |
EPS (LTM) |
-0.84 |
Other stocks of industry "Biotechnology"
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.